In Brief: Perkin-Elmer/Roche/Amersham:
This article was originally published in The Gray Sheet
Executive Summary
Perkin-Elmer/Roche/Amersham: Companies enter royalty-bearing cross-licensing agreement giving Amersham "non-exclusive licenses and sublicenses" to automated fluorescent DNA sequencing patents owned by Perkin-Elmer, DuPont and the California Institute of Technology and non-exclusive licenses under "certain Roche patents covering thermostable polymerases for use in sequencing." Perkin-Elmer's PE Applied Biosystems division and Roche Molecular Systems receive non-exclusive licenses and sublicenses to patents owned by Amersham and Harvard University "which enable the companies to manufacture, use, and sell a wider range of kits and DNA polymerases for DNA sequencing and fragment analysis"...
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.